Buprenorphine Prescriber Training

APA offers a number of training approaches for medication assisted treatment.

The 8-hour training activities below meet the Federal training requirement of the Drug Addiction Treatment Act of 2000 (DATA 2000). Completion will allow qualified physicians to apply for a waiver to their Drug Enforcement Administration (DEA) license, and thus to provide office-based treatment of opioid use disorder with buprenorphine. Physicians wishing to become waiver eligible can complete any one of the activities below.

Educational Offerings

Learning Method	Registration	Complete Quiz, Evaluation, and Credit Claim
Book-based Learning – Office-Based Buprenorphine Treatment of Opioid Use Disorder, Second Edition	Purchase	Claim Credit
Online Training	Purchase	Claim Credit
Live Learning at the 2019 APA Annual Meeting	Coming soon	Coming soon

Instructions for Applying for a Buprenorphine Waiver

Once you have completed one of the above trainings and claimed your CME credit, APA will report your completion to SAMHSA. To claim your Buprenorphine Waiver, you must go to SAMSHA's "Buprenorphine Waiver Notification" website no sooner than 15 days from now. APA sends SAMSHA notifications of waiver training completion biweekly, and your information will be included in our next transmission.